Advantages of the use of the stem cell secretome in the treatment of lesions in horses

Specific proteins secreted by stem cells could be a safer and easier alternative to administer.

To help injured joints and support soft tissues after trauma or injury, a multimodal approach is recommended. In addition to anti-inflammatory medications, therapeutic options include high-quality joint supplements, extracorporeal shock wave therapy, and regenerative therapies such as stem cells and platelet-rich plasma. Scientists have recently pointed out that horses do not need real stem cells to speed healing, only specific proteins secreted by the stem cells' secretome.

Stem cell therapy

Stem cell therapy has been available in equine medicine for years. Stem cells stimulate and coordinate the healing process and are most often used for joint, tendon, and ligament injuries. These specialized cells are usually isolated from fat or bone marrow, either from the injured horse or from a donor horse. Several administration routes are possible; however, veterinarians prefer direct injection into the injury or affected joint.

“There are some potential drawbacks to injecting stem cells into injured or traumatized horses. For example, there is a delay between injury and injection due to the time it takes to process stem cells. Additionally, inflammation or infection can develop after injection, especially if stem cells from a donor horse are used, ”noted Catherine Whitehouse, MS, of Kentucky Equine Research.

What are the advantages of using the stem cell secretome?

One way to speed up the treatment process is by using the stem cell secretome. “These protein molecules supposedly have the same functions as stem cells themselves, such as anti-inflammatory and pro-regenerative characteristics. Furthermore, they are less likely to elicit an immune response, thus avoiding adverse reactions, ”Whitehouse added.

Stem cell secretome can be manufactured and stored as a ready-to-use powder that only requires mixing with saline before injection. This prolongs the product's shelf life and avoids the problems associated with cell damage or death during processing, shipping, and administration.

Equine Injuries, Lameness. Kentucky Equine Research Staff

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

World Veterinary Dermatology Day


Artificial insemination market to grow to $3B by 2028


February is National Pet Dental Health Month


Falling markets? Don't panic, it's not the first time


Treatment of canine chronic cutaneous lupus erythematosus with oclacitinib




News of interest


Copyright © 2023 - All Rights Reserved
ISSN 2768-198X